A

Arizona Research Center | Phoenix, AZ

Research site
(Unclaimed)
Location
15601 N. 28th Avenue, Suite 100, Phoenix, Arizona, United States of America
Site insights

Top conditions

Osteoarthritis (28 trials)

Low Back Pain (18 trials)

Back Pain (17 trials)

Postoperative Pain (16 trials)

Diabetic Neuropathies (16 trials)

Top treatments

Buprenorphine
Pregabalin
VX-548
Apremilast
Fentanyl
Hydrocodone Bitartrate
LY3857210
Bupivacaine HCl
Galcanezumab
Tanezumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

12 of 148
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy (REGAiN-1B)

To evaluate the durability of efficacy and long-term safety of intramuscular (IM) administration of Engensis or Placebo that was administered in the...

Enrolling
Diabetic Peripheral Neuropathy
Biological: Engensis
Other: Placebo

This is a longitudinal follow-up study of the RC-002 study, in which up to 246 subjects assigned to two randomization arms will be enrolled: an adipo...

Invitation-only
Partial Thickness Rotator Cuff Tear
Device: Corticosteroid
Device: Adipose Derived Regenerative Cells

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-s...

Enrolling
Chronic Low-back Pain
Diabetic Neuropathic Pain
Drug: LY3526318 ISA
Drug: LY3857210 ISA

This is a 2-part, randomized, placebo-controlled, double-blind, Phase 2 study to evaluate the safety, tolerability, efficacy, and PK of RTA 901 in qu...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Placebo
Drug: RTA 901

The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master pr...

Enrolling
Overweight
Knee Pain Chronic
Drug: Retatrutide
Drug: Placebo

The main purpose of this study is to evaluate the safety and efficacy of retatrutide once-weekly in participants who have obesity or are overweight a...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

The purpose of this investigation is to evaluate the safety and superior effectiveness in functional improvement in patients with partial-thickness r...

Active, not recruiting
Rotator Cuff Tear
Rotator Cuff Tendinitis
Device: Adipose Derived Regenerative Cells
Drug: Corticosteroid

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Enrolling
Painful Lumbosacral Radiculopathy
Drug: VX-548
Drug: Placebo

The main purpose of this study is to characterize the long-term safety and efficacy of the drug Deucravacitinib (BMS-986165) in patients who have bee...

Active, not recruiting
Psoriasis
Drug: BMS-986165

The purpose of this study is to evaluate the efficacy and safety of intramuscular (IM) administration of Engensis on pain in participants with painfu...

Active, not recruiting
Diabetic Neuropathy, Painful
Other: Placebo
Biological: Engensis

This two-part study will be conducted in male and female patients, 30 - 80 years of age with painful OA of the index knee with Kellgren-Lawrence (K-L...

Active, not recruiting
Osteoarthritis, Knee
Biological: FX201

VALO-2 is a multicenter, open-label extension (OLE) study enrolling patients with genotyped keratin mutations KRT6A, KRT6B and KRT16 who were previou...

Active, not recruiting
Pachyonychia Congenita
Drug: PTX-022

Trial sponsors

Pfizer logo

Pfizer (17 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems